AV¶ÌÊÓÆµ

PATIM Seminar Series

2017/09 - 2018/06

Date Ìý Time Ìý Location Ìý Speaker Ìý Title Ìý Host Ìý Details Ìý
SEPTEMBER
FRI
15
Ìý 11h-12h Ìý E07.3347.A Ìý AV¶ÌÊÓÆµ of Kiel, Germany Ìý IL-6 in the control of Inflammation and Cancer Ìý C. Gabay Ìý Ìý Ìý
FRI
29
Ìý 11h-12h Ìý E07.3347.A Ìý TBD Ìý Ìý Ìý Ìý Ìý Ìý Ìý
OCTOBER
FRI
13
Ìý 11h-12h Ìý E07.3347.A Ìý Massachussetts General Hospital Boston, USA Ìý Uncovering single-cell regulatory programs in adult and pediatric gliomas Ìý D. Merkler Ìý Ìý Ìý
FRI
20
Ìý 11h-12h Ìý E07.3347.A Ìý AV¶ÌÊÓÆµ of Bern Ìý Transcriptional and post-transcriptional regulation of immunopathology Ìý J. Bertrand Ìý Ìý Ìý
NOVEMBER
FRI
3
Ìý 11h-12h Ìý E07.3347.A Ìý AV¶ÌÊÓÆµ of Lausanne Ìý A new role for neutrophils in response to infection with Leishmania parasites Ìý I. Garcia-Gabay Ìý Ìý Ìý
FRI
17
Ìý 11h-12h Ìý E07.3347.A Ìý
CHUV, Lausanne
Ìý Psoriasis: Paradoxical and non-paradoxical Ìý W.-H. Boehnke Ìý Ìý Ìý
DECEMBER
FRI
1
Ìý 11h-12h Ìý E07.3347.A Ìý Pasteur Institute, Paris, France Ìý Decoding immune responses to cancer and infections using intravital imaging Ìý S. Hugues Ìý Ìý Ìý
JANUARY
FRI
26
Ìý 11h-12h Ìý E07.3347.A Ìý Chantal BoulangerINSERM, ±«²Ô¾±±¹±ð°ù²õ¾±³Ùé Paris-Descartes Ìý Extracellular vesicles and cardiovascular diseases Ìý M.L. Bochaton-Piallat Ìý Ìý Ìý
FEBRUARY
FRI
9
Ìý 11h-12h Ìý E07.3347.A Ìý AV¶ÌÊÓÆµ Hospital Basel Ìý MR1T cells, a new population of human MR1-restricted T cells Ìý W. Reith Ìý Ìý Ìý
FRI
23
Ìý 11h-12h Ìý E07.3347.A Ìý Lund AV¶ÌÊÓÆµ Sweden Ìý Cellular Reprogramming in Hematopoiesis and Immunity Ìý J. Bertrand Ìý Ìý Ìý
MARCH
FRI
9
Ìý 11h-12h Ìý E07.3347.A Ìý AMC, Amsterdam, Netherlands Ìý

Immune checkpoints: targets for cardiovascular disease?

Ìý B. Kwak Ìý Ìý Ìý
FRI
23
Ìý 11h-12h Ìý E07.3347.A Ìý Centre de Physiothologie de Toulouse-Purpan Ìý

Foxo3-Eomes axes in CD4 T cell differentiation and function

Ìý D. Merkler J. Bertrand Ìý Ìý Ìý
APRIL
FRI
13
Ìý 11h-12h Ìý E07.3347.A Ìý AV¶ÌÊÓÆµ of Cambridge, UK Ìý Generalists and specialists: a new view of how MHC class I molecules fight disease Ìý W. Reith
B. Imhof
Ìý Ìý Ìý
FRI
27
Ìý 11h-12h Ìý E07.3347.A Ìý Institut of Clinical Neuroimmunology, Munich Ìý In vivo analysis of phagocyte phenotypes and effector function in CNS inflammation Ìý D. Merkler Ìý Ìý Ìý
MAY
FRI
18
Ìý 11h-12h Ìý E07.3347.A Ìý Department of Medicine, AV¶ÌÊÓÆµ of Cambridge, UK Ìý
Lessons from the zebrafish for human susceptibility to tuberculosis and its treatment
Ìý J. Bertrand Ìý Ìý Ìý
JUNE
Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý